stella
beta
Glypican-3 as a Prognostic Factor in Patients With Hepatocellular Carcinoma Treated by Immunotherapy — Stella
Home
/
Hepatocellular Carcinoma
/
Glypican-3 as a Prognostic Factor in Patients With Hepatocellular Carcinoma Treated by Immunotherapy
View on ClinicalTrials.gov
Recruiting
Back to Hepatocellular Carcinoma trials
Glypican-3 as a Prognostic Factor in Patients With Hepatocellular Carcinoma Treated by Immunotherapy
Trial locations
(1 site)
France
Service hépato-gastroentérologie, Hôpital la Pitié-Salpêtrière, Paris